MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 13.3% of their position (50K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $21.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/19/2025ACC: 0001477932-25-003965
Officer· Chief Scientific Officer
+50K
Net shares
Net buyer
$21.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$0.43
Trade value
$21.50K
% of position
13.3%
—
376.03K→426.03K
Total
Net shares
+50K
Net value
$21.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +50K | $0.43 | $21.50K | 13.3% | 376.03K | 426.03K |
| Total | +50K | $21.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned38.11K
Common Stock
IndirectShares owned55K
Total
93.11K indirect93.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.11K | Indirect |
| Common Stock | 55K | Indirect |
| Total | 93.11K | 93.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported